Johnson & Johnson to acquire Momenta Pharma for $6.5 billion
This deal gives J&J access to a new class of drugs that treat autoimmune diseases.
Johnson & Johnson Loses Baby Powder And Ovarian Cancer Case
Johnson & Johnson (J&J) faced a historically expensive compensation charge on Thursday, July 12, 2018. A Missouri Jury ordered the American baby product giant to pay a reco
Alex Gorsky to be Johnson & Johnson's new CEO After Weldon
Johnson & Johnson has picked up a new CEO, to succeed Bill Weldon after his retirement in April this year. The healthcare giant J&J said its decade-old Chief Executive Of
